| -0.08 / -0.26%|
The 11 analysts offering 12-month price forecasts for Mindray Medical International Ltd have a median target of 32.00, with a high estimate of 44.79 and a low estimate of 23.00. The median estimate represents a +3.39% increase from the last price of 30.95.
The current consensus among 12 polled investment analysts is to Hold stock in Mindray Medical International Ltd. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.